首页> 外文期刊>AJNR. American journal of neuroradiology >Recanalization with wingspan stent for acute middle cerebral artery occlusion in failure or contraindication to intravenous thrombolysis: A feasibility study
【24h】

Recanalization with wingspan stent for acute middle cerebral artery occlusion in failure or contraindication to intravenous thrombolysis: A feasibility study

机译:翼展支架再通用于急性脑中动脉阻塞或静脉溶栓的禁忌症的可行性研究

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Recanalization with the Wingspan stent, which can be deployed rapidly and safely, is an option for treating acute ischemic stroke when intravenous thrombolysis has failed or is contraindicated. This study was performed to evaluate feasibility, efficacy, and safety of recanalization for acute middle cerebral artery occlusion using the Wingspan stent. MATERIALS AND METHODS: We collected 10 patients with acute MCA occlusion in whom recanalization was not achieved with a standard intravenous thrombolysis, or who were ineligible for intravenous thrombolysis, or who presented after 3 hours of symptom onset and in whom the stent placement could be completed within 8 hours from symptom onset. We analyzed angiographic and clinical results. RESULTS: Successful recanalization with the Wingspan stent was achieved in all patients. The mean NIHSS score on admission was 12.7 points (range 4-21). The occlusion sites were located in the 1st segment (n = 7; 2 left, 5 right) and 2nd segment (n = 3, all right) of the MCA. The mean time interval from stroke symptom onset to stent placement was 344.8 ± 76.3 minutes. No intracranial hemorrhage, vessel perforations, or dissections occurred in any patient. Nine patients improved on the NIHSS at 7 days. One patient did not have a change in the NIHSS score, even though the occluded artery was completely recanalized. At 7 days, the NIHSS score of all patients was 4.4 ± 4.7 (median 4, range 0-13). At discharge, an mRS of ≤3 was achieved in all patients and an mRS of ≤2 was achieved in 7 patients (70%). CONCLUSIONS: This small case series demonstrates the feasibility of using the Wingspan stent safely and effectively for MCA occlusions when standard treatments are ineffective or not available.
机译:背景与目的:当静脉溶栓失败或禁忌时,可以快速,安全地部署Wingspan支架进行再通是治疗急性缺血性中风的一种选择。进行这项研究以评估使用Wingspan支架进行急性中脑动脉阻塞的再通的可行性,疗效和安全性。材料与方法:我们收集了10例急性MCA闭塞患者,这些患者在标准的静脉溶栓治疗中无法再通,或者不适合进行静脉溶栓治疗,或者在症状发作3小时后就诊并且可以完成支架置入症状发作后8小时内。我们分析了血管造影和临床结果。结果:所有患者均成功使用Wingspan支架再通。入院时NIHSS的平均得分为12.7分(范围4-21)。闭塞位点位于MCA的第一部分(n = 7;左2,右5)和第二部分(n = 3,所有右)。从中风症状发作到支架置入的平均时间间隔为344.8±76.3分钟。任何患者均未发生颅内出血,血管穿孔或解剖。 7天时有9例患者的NIHSS改善。即使闭塞的动脉完全再通,一名患者的NIHSS评分也没有改变。在第7天,所有患者的NIHSS评分为4.4±4.7(中位数4,范围0-13)。出院时,所有患者的mRS≤3,并且7例(70%)的mRS≤2。结论:这个小病例系列证明了当标准治疗无效或无法使用时,将Wingspan支架安全有效地用于MCA闭塞的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号